Cargando…
Survival After MI in a Community Cohort Study Contribution of Comorbidities in NSTEMI
BACKGROUND: Non–ST-segment elevation myocardial infarction (NSTEMI) comprises the majority of MI worldwide, yet mortality remains high. Management of NSTEMI is relatively delayed and heterogeneous compared with the “time is muscle” approach to ST-segment elevation MI, though it is unknown to what ex...
Autores principales: | Foraker, Randi E., Guha, Avirup, Chang, Henry, O’Brien, Emily C., Bower, Julie K., Crouser, Elliott D., Rosamond, Wayne D., Raman, Subha V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963709/ https://www.ncbi.nlm.nih.gov/pubmed/29409724 http://dx.doi.org/10.1016/j.gheart.2018.01.002 |
Ejemplares similares
-
Acute Pulmonary Edema and NSTEMI
por: Pilgrim, Ashley
Publicado: (2023) -
Neighborhood socioeconomic status, Medicaid coverage and medical management of myocardial infarction: Atherosclerosis risk in communities (ARIC) community surveillance
por: Foraker, Randi E, et al.
Publicado: (2010) -
European NSTEMI guidelines—return of clopidogrel?
por: Dannenberg, Lisa, et al.
Publicado: (2021) -
Oral Antiplatelet Therapy Administered Upstream to Patients With NSTEMI
por: Pollack, Charles V., et al.
Publicado: (2020) -
CORONARY CONSIDERATIONS FOR THROMBOSIS IN COVID-19 NSTEMI
por: Wilbanks, David, et al.
Publicado: (2022)